Search for: "Ely Lilly"
Results 101 - 120
of 2,172
Sort by Relevance
|
Sort by Date
3 May 2022, 5:35 pm
We discussed this with regard to OPDP’s recent Untitled Letter to Eli Lilly that raised issues with adequate communication of information (despite the fact that the relevant information was included within the ad). [read post]
28 Apr 2022, 7:25 am
Eli Lilly and Company, 598 F.3d 1336 (Fed. [read post]
16 Apr 2022, 2:49 pm
Eli Lilly & Co., 8 F.4th 1349 (Fed. [read post]
17 Mar 2022, 2:32 pm
Eli Lilly & Co., 119 F.3d 1559, 1568 (Fed. [read post]
11 Feb 2022, 12:57 pm
During this past 12 months, to the day, we have written these 12 earlier Drug Injury Watch articles which are relevant to Xeljanz, Rinvoq, and Olumiant, given that they are about JAK inhibitors drug class safety and JAK inhibitors label changes: Xeljanz FDA Drug Safety Communication in February 2021 Puts Heightened Scrutiny on Pfizer (February 11, 2021) Xeljanz Has A New Drug Safety Issue, We Just Don't Know How Significant It Is, Yet (February 17, 2021) Possible Ramifications of Recent FDA… [read post]
10 Feb 2022, 6:13 am
Among CGRP medications, Amgen’s Aimovig lead “with 8% of patients recalling the brand, followed by Eli Lilly’s Emgality and Biohaven’s Nurtec ODT (both 7%) and Teva’s Ajovy (3%). [read post]
25 Jan 2022, 7:51 am
COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don't work against the omicron variant, U.S. health regulators said. [read post]
14 Jan 2022, 12:05 pm
Xeljanz is a Pfizer drug, Olumiant is an Eli Lilly drug, and Rinvoq is an AbbVie drug. [read post]
9 Jan 2022, 1:45 am
The written description requirement has been interpreted as requiring demonstration in the specification that the patent applicant "has invented species sufficient to support a claim to the functionally-defined genus" (Ariad v Eli Lilly). [read post]
5 Jan 2022, 6:40 pm
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
17 Dec 2021, 12:52 pm
PPAC Members: Steven Caltrider (Chair) – VP and General Patent Counsel, Eli Lilly and Company; Tracy-Gene Durkin (Vice Chair) – Director at Sterne Kessler; Jeffrey Sears – Associate General Counsel and Chief Patent Counsel at Columbia University; Jeremiah Chan – Director and Associate General Counsel at Meta (FB); Daniel Brown – Professor at the Segal Design Institute of Northwestern University; Judge Susan Braden – Former Judge of the Ct. [read post]
17 Dec 2021, 8:44 am
” Heidi will be joined on the board by a distinguished group of current board members including, Steven Caltrider, Chair and Vice President and General Patent Counsel at Eli Lilly and Company; Tracy-Gene G. [read post]
11 Dec 2021, 8:25 pm
Patent and Trademark Office; Mark Stewart of Eli Lilly and Co.; and Todd Walters of Buchanan Ingersoll & Rooney PC will discuss the best practices and emerging trends from pre-institution through final hearing, including strategies focused on petition drafting, preliminary patent owner responses, discretionary denial considerations,... [read post]
9 Dec 2021, 11:02 am
As we wrote about in this recent article, "Eli Lilly Attempts to Distance Olumiant From the Ominous JAK Inhibitors Drug Class Safety Issues Flagged by FDA", the pharmaceutical companies AbbieVie and Eli Lilly have attempted to distinguish the safety profile of their respective JAK inhibitors drug product from the various adverse drug reactions that have been observed in the Xeljanz clinical trial that have driven the FDA regulatory actions driving these… [read post]
30 Nov 2021, 9:36 am
Eli Lilly & Co., 598 F.3d 1336 (Fed. [read post]
29 Nov 2021, 1:55 pm
As background, Xeljanz is a Pfizer drug, Rinvoq is an AbbVie drug, and Olumiant is an Eli Lilly drug. [read post]
27 Nov 2021, 2:12 pm
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
26 Oct 2021, 4:15 am
As an example, Eli Lilly stock price jumped 10.2% on June 7, or a hike of $18.6 billion in market cap, because the company also has a similar drug candidate. [read post]
26 Oct 2021, 4:15 am
As an example, Eli Lilly stock price jumped 10.2% on June 7, or a hike of... [read post]
17 Sep 2021, 12:18 pm
In Eli Lilly and Co. v. [read post]
